[Skip to Navigation]
May 1973

Use of the Nitroblue Tetrazolium Dye Test: An Aid in Managing Patients With Cystic Fibrosis

Author Affiliations

New Haven, Conn
From the Department of Pediatrics, Yale University School of Medicine, New Haven, Conn.

Am J Dis Child. 1973;125(5):702-704. doi:10.1001/archpedi.1973.04160050056010

One hundred fifty-seven nitroblue tetrazolium (NBT) dye tests were performed on 78 patients with cystic fibrosis. A "positive" NBT response of >10% was significantly correlated with the presence of presumed bacterial respiratory infection, and stable patients had "normal" NBT scores below 10%.

Serial determinations in 16 instances of bacterial infection were helpful in evaluating response to therapy. Total leukocyte count, mean percentage of immature polymorphonuclear leukocytes, temperature, or a change in sputum flora were not helpful in detecting bacterial infection in these patients. The NBT test is a valuable adjunct in the surveillance of patients with cystic fibrosis.

Add or change institution